Pathophysiology of Cav1.3 L-type calcium channels in the heart

Front Physiol. 2023 Mar 21:14:1144069. doi: 10.3389/fphys.2023.1144069. eCollection 2023.

Abstract

Ca2+ plays a crucial role in excitation-contraction coupling in cardiac myocytes. Dysfunctional Ca2+ regulation alters the force of contraction and causes cardiac arrhythmias. Ca2+ entry into cardiomyocytes is mediated mainly through L-type Ca2+ channels, leading to the subsequent Ca2+ release from the sarcoplasmic reticulum. L-type Ca2+ channels are composed of the conventional Cav1.2, ubiquitously expressed in all heart chambers, and the developmentally regulated Cav1.3, exclusively expressed in the atria, sinoatrial node, and atrioventricular node in the adult heart. As such, Cav1.3 is implicated in the pathogenesis of sinoatrial and atrioventricular node dysfunction as well as atrial fibrillation. More recently, Cav1.3 de novo expression was suggested in heart failure. Here, we review the functional role, expression levels, and regulation of Cav1.3 in the heart, including in the context of cardiac diseases. We believe that the elucidation of the functional and molecular pathways regulating Cav1.3 in the heart will assist in developing novel targeted therapeutic interventions for the aforementioned arrhythmias.

Keywords: atrial fibrillation; calcium channel; heart failure; protein kinase regulation; sinoatrial node dysfunction.

Publication types

  • Review

Grants and funding

This work was supported by a Merit Review grant I01 BX002137 from Biomedical Laboratory Research & Development Service of Veterans Affairs Office of Research and Development to MB; National Heart, Lung, and Blood Institute 1R01HL164415-01 to MB; and US Department of Defense award number W81XWH-21-1-0424 to MB; and the Canadian Institutes of Health Research grant (MOP-130373) to MC; a US. Department of Defense grant (USAMRAA W81XWH-21-1-0426) to MC